The investigators compared 137 national essential medicines lists with the WHO EML to separate two distinct dimensions of national adaptation: how closely countries adopt WHO recommendations and how extensively they add medicines beyond that benchmark. They reported two quantitative metrics. The Alignment Ratio measured the share of WHO-recommended medicines appearing on each national list. The Expansion Ratio measured the share of medicines on each national list that were not present on the WHO list. Short, direct definitions framed the analysis; the study team then used those scores to examine cross-national heterogeneity in policy choices and list composition.
Countries were not clustered at one pole. The cohort showed representation across four adaptation modes defined by combinations of high/low alignment and high/low expansion. Fifty countries fell into a restrictive/constrained adoption category (low alignment, low expansion). Thirty-five countries matched a normative dependence pattern (high alignment, low expansion). Sixteen countries were classified as autonomous divergence (low alignment, high expansion). Thirty-six countries combined high alignment with high expansion and were labeled capacity-driven expansion. The authors reported this distribution without adding interpretation beyond the classification counts, letting the numbers speak to the variety of national trajectories relative to the WHO benchmark.
Multivariable beta regression identified country-level associations with each ratio. Higher under-five mortality was associated with lower Alignment Ratio (β = −0.294; 95% CI: −0.497 to −0.091). The same mortality signal associated with lower Expansion Ratio as well (β = −0.481; 95% CI: −0.697 to −0.264). The study team also reported that higher globalization index scores and more recently updated national lists were associated with higher alignment, but those factors were not associated with expansion. The authors did not report other country-level predictors beyond those summarized in the abstract; details of all covariates tested and full model outputs are available from the preprint and underlying data on request.
The authors constructed two independent measures to capture different policy choices: alignment versus supplementation. They compared each national list directly to the WHO Model List and calculated the two ratios described above. Associations between country characteristics and the two ratios were tested using multivariable beta regression. The abstract presents the key regression coefficients and confidence intervals for under-five mortality and summarizes associations for globalization and list recency. The source did not report additional trial-like parameters such as sensitivity analyses or alternative modeling approaches in the abstract; interested readers should consult the full preprint or the authors for model specifications, variable coding, and other analytic details.
All data produced in the study are available upon reasonable request to the authors, according to the preprint record. The article is posted on medRxiv as a preprint and has not been certified by peer review; the authors and medRxiv note that the findings should not yet be used to guide clinical practice or national policy without further evaluation. The abstract provides key outcomes and several regression estimates, but it does not enumerate study limitations in detail. For example, the source did not report in the abstract whether temporal changes in WHO recommendations or national list timing were modeled beyond the single recency measure it mentions, nor did it specify whether list composition differences were adjusted for therapeutic class distributions. Those unanswered analytic details and any peer-review revisions remain to be clarified by the authors and future review.
The primary empirical conclusion reported by the investigators is clear: while some countries closely followed the WHO EML with limited additions, a substantial proportion combined high alignment with extensive expansion, indicating that national adaptation often supplements WHO recommendations rather than replaces them. Data and analytic details are available from the authors on request, and readers should interpret the results in the context of the paper's preprint status and pending peer review.